These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35040506)

  • 1. mTOR Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double-Blind, Placebo-Controlled Futility Trial and 1-Year Biomarker Longitudinal Analysis.
    Palma JA; Martinez J; Millar Vernetti P; Ma T; Perez MA; Zhong J; Qian Y; Dutta S; Maina KN; Siddique I; Bitan G; Ades-Aron B; Shepherd TM; Kang UJ; Kaufmann H
    Mov Disord; 2022 Apr; 37(4):778-789. PubMed ID: 35040506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial.
    Levin J; Maaß S; Schuberth M; Giese A; Oertel WH; Poewe W; Trenkwalder C; Wenning GK; Mansmann U; Südmeyer M; Eggert K; Mollenhauer B; Lipp A; Löhle M; Classen J; Münchau A; Kassubek J; Gandor F; Berg D; Egert-Schwender S; Eberhardt C; Paul F; Bötzel K; Ertl-Wagner B; Huppertz HJ; Ricard I; Höglinger GU;
    Lancet Neurol; 2019 Aug; 18(8):724-735. PubMed ID: 31278067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial.
    Low PA; Robertson D; Gilman S; Kaufmann H; Singer W; Biaggioni I; Freeman R; Perlman S; Hauser RA; Cheshire W; Lessig S; Vernino S; Mandrekar J; Dupont WD; Chelimsky T; Galpern WR
    Lancet Neurol; 2014 Mar; 13(3):268-75. PubMed ID: 24507091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuron-derived extracellular vesicles to examine brain mTOR target engagement with sirolimus in patients with multiple system atrophy.
    Pucha KA; Ma TC; York W; Kang UJ; Kaufmann H; Kapogiannis D; Palma JA
    Parkinsonism Relat Disord; 2023 Oct; 115():105821. PubMed ID: 37643509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA-FLUO Trial.
    Rascol O; Cochen de Cock V; Pavy-Le Traon A; Foubert-Samier A; Thalamas C; Sommet A; Rousseau V; Perez-Lloret S; Fabbri M; Azulay JP; Corvol JC; Couratier P; Damier P; Defebvre L; Durif F; Geny C; Houeto JL; Remy P; Tranchant C; Verin M; Tison F; Meissner WG;
    Mov Disord; 2021 Jul; 36(7):1704-1711. PubMed ID: 33792958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trial.
    Poewe W; Seppi K; Fitzer-Attas CJ; Wenning GK; Gilman S; Low PA; Giladi N; Barone P; Sampaio C; Eyal E; Rascol O;
    Lancet Neurol; 2015 Feb; 14(2):145-52. PubMed ID: 25498732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cinpanemab in Early Parkinson Disease: Evaluation of Biomarker Results From the Phase 2 SPARK Clinical Trial.
    Hutchison RM; Fraser K; Yang M; Fox T; Hirschhorn E; Njingti E; Scott D; Bedell BJ; Kistner KM; Cedarbaum JM; Evans KC; Graham D; Martarello L; Mollenhauer B; Lang AE; Dam T; Beaver J
    Neurology; 2024 Mar; 102(5):e209137. PubMed ID: 38315945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inosine 5'-Monophosphate to Raise Serum Uric Acid Level in Multiple System Atrophy (IMPROVE-MSA study).
    Jung Lee J; Han Yoon J; Jin Kim S; Soo Yoo H; Jong Chung S; Hyun Lee Y; Yun Kang S; Shin HW; Keun Song S; Yong Hong J; Sunwoo M; Eun Lee J; Sam Baik J; Sohn YH; Hyu Lee P
    Clin Pharmacol Ther; 2021 May; 109(5):1274-1281. PubMed ID: 33064299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of mesenchymal stem cells in multiple system atrophy.
    Lee PH; Lee JE; Kim HS; Song SK; Lee HS; Nam HS; Cheong JW; Jeong Y; Park HJ; Kim DJ; Nam CM; Lee JD; Kim HO; Sohn YH
    Ann Neurol; 2012 Jul; 72(1):32-40. PubMed ID: 22829267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of multiple system atrophy in the USA: a prospective cohort study.
    Low PA; Reich SG; Jankovic J; Shults CW; Stern MB; Novak P; Tanner CM; Gilman S; Marshall FJ; Wooten F; Racette B; Chelimsky T; Singer W; Sletten DM; Sandroni P; Mandrekar J
    Lancet Neurol; 2015 Jul; 14(7):710-9. PubMed ID: 26025783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial.
    NINDS Exploratory Trials in Parkinson Disease (NET-PD) FS-ZONE Investigators
    Lancet Neurol; 2015 Aug; 14(8):795-803. PubMed ID: 26116315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalities on structural MRI associate with faster disease progression in multiple system atrophy.
    Krismer F; Seppi K; Wenning GK; Papapetropoulos S; Abler V; Goebel G; Schocke M; Poewe W
    Parkinsonism Relat Disord; 2019 Jan; 58():23-27. PubMed ID: 30145124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of adjunctive bitopertin versus placebo in patients with suboptimally controlled symptoms of schizophrenia treated with antipsychotics: results from three phase 3, randomised, double-blind, parallel-group, placebo-controlled, multicentre studies in the SearchLyte clinical trial programme.
    Bugarski-Kirola D; Iwata N; Sameljak S; Reid C; Blaettler T; Millar L; Marques TR; Garibaldi G; Kapur S
    Lancet Psychiatry; 2016 Dec; 3(12):1115-1128. PubMed ID: 27816567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.
    Aggarwal SP; Zinman L; Simpson E; McKinley J; Jackson KE; Pinto H; Kaufman P; Conwit RA; Schoenfeld D; Shefner J; Cudkowicz M;
    Lancet Neurol; 2010 May; 9(5):481-8. PubMed ID: 20363190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors impacting quality of life in multiple system atrophy.
    Ali N; Nesspor V; Bang J; Scholz SW; Pantelyat A
    Front Neurol; 2023; 14():1111605. PubMed ID: 36970533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG).
    Geser F; Wenning GK; Seppi K; Stampfer-Kountchev M; Scherfler C; Sawires M; Frick C; Ndayisaba JP; Ulmer H; Pellecchia MT; Barone P; Kim HT; Hooker J; Quinn NP; Cardozo A; Tolosa E; Abele M; Klockgether T; Østergaard K; Dupont E; Schimke N; Eggert KM; Oertel W; Djaldetti R; Poewe W;
    Mov Disord; 2006 Feb; 21(2):179-86. PubMed ID: 16161136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose ubiquinol supplementation in multiple-system atrophy: a multicentre, randomised, double-blinded, placebo-controlled phase 2 trial.
    Mitsui J; Matsukawa T; Uemura Y; Kawahara T; Chikada A; Porto KJL; Naruse H; Tanaka M; Ishiura H; Toda T; Kuzuyama H; Hirano M; Wada I; Ga T; Moritoyo T; Takahashi Y; Mizusawa H; Ishikawa K; Yokota T; Kuwabara S; Sawamoto N; Takahashi R; Abe K; Ishihara T; Onodera O; Matsuse D; Yamasaki R; Kira JI; Katsuno M; Hanajima R; Ogata K; Takashima H; Matsushima M; Yabe I; Sasaki H; Tsuji S
    EClinicalMedicine; 2023 May; 59():101920. PubMed ID: 37256098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.